跳至主要内容
临床试验/CTRI/2025/09/094885
CTRI/2025/09/094885尚未招募2/3 期

A Randomized Controlled Clinical Study Of Efficacy Of Triphala, Shunthi, Nimba, Lodhra and Atarushaka Kwatha Aashchyotan in Kaphabhishyanda With Special Reference To Simple Allergic conjunctivitis.

vdswapnali ramesh patekar1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2025年9月30日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
33
试验地点
1
主要终点
Aashchyotan in Kaphabhishyanda With Special Reference To Simple Allergic

研究概览

简要总结

This is a clinical study of efficacy of trihala,shunthi,nimb,lodhra,attarushak kwath aashchyotan in kaphaj abhishandya with special reference to simple allergic conjuctivitis ,kwath in the form of 2 drops qid for 14 days given to trial group while daruharidra kwath with madhu aashchyotan will be given for control group.The primary objective is to study the role of trial group drug to reduce the symptoms of simple allergic conjunctivitis.

the data will be assessed for decreasing the symptoms like lacrimation,itching ,conjuctival congestion using gradation chart.the study will be conducted at our centre institute.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
10.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed patients with signs and symptoms of Simple Allergic conjunctivitis /Kaphabhishyanda.
  • Patient of 10 to 50 years age group of either gender.
  • Patients willing for Treatment.
  • Uncomplicated Simple Allergic Con.

排除标准

  • Associated with other forms of allergic conditions like skin rash, allergic bronchitis, Atopic and systemic allergic problems.
  • Cases complicated with superadded infections and corneal ulcers.
  • Patients not willing for treatment.
  • Other active infectious systemic disorders / Ophthalmic disord.

结局指标

主要结局

Aashchyotan in Kaphabhishyanda With Special Reference To Simple Allergic

时间窗: 14 days

conjunctivitis.

时间窗: 14 days

To study the role of Triphala, Shunthi, Nimba, Lodhra and Atarushaka Kwatha

时间窗: 14 days

次要结局

  • To reduce symptoms of simple allergic conjunctivitis.(• To establish the efficacy of Triphala, Shunthi, Nimba, Lodhra and Atarushaka)

研究者

发起方
vdswapnali ramesh patekar
申办方类型
Other [self sponsored]
责任方
Principal Investigator
主要研究者

Vd SWAPNALI RAMESH PATEKAR

Government Ayurvedic College And Hospital Nanded

研究点 (1)

Loading locations...

相似试验

A Study of Triphala, Shunthi, Nimba, Lodhra and... | 临床试验